The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR(PDF, 524KB) and Technical Notes(PDF, 752KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 13.30

Acute Lymphocytic Leukemia

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2014
By Race/Ethnicity, Sex and Years Since Diagnosis

WARNING: The Prevalence Estimates presented on this page utilize a different tumor selection criteria from previous CSR releases and are NOT directly comparable to estimates from previous CSR releases.
Please see the Prevalence Comparison Chapter of this CSR for more information.

Race/Ethnicity Sex Years Since Diagnosis Completeh
0 to <5 5 to <10 10 to <15 15 to <20 20 to <25 25 to <30 0 to <22e 0 to <39e >=39g
All Races b Both Sexes 17,937 14,284 11,945 10,606 8,696 6,700 61,761 78,275 3,562 81,837
Males 9,674 8,187 6,578 5,857 4,673 3,627 34,012 42,662 1,823 44,485
Females 8,263 6,097 5,367 4,749 4,023 3,073 27,749 35,613 1,739 37,352
White b Both Sexes 15,053 12,021 10,395 9,230 7,614 5,914 52,826 67,715 + +
Males 8,045 6,797 5,742 5,031 4,189 3,234 28,969 36,835 + +
Females 7,008 5,224 4,653 4,199 3,425 2,680 23,857 30,880 + +
Black b Both Sexes 1,532 1,167 715 684 576 339 4,555 5,339 + +
Males 916 798 330 393 258 155 2,619 2,990 + +
Females 616 369 385 291 318 184 1,936 2,349 + +
Asian/
Pacific
Islander c		 Both Sexes 829 722 524 527 + + 2,768 + + +
Males 447 393 320 318 + + 1,552 + + +
Females 382 329 204 209 + + 1,216 + + +
Hispanic d Both Sexes 5,567 4,212 2,843 2,476 + + 15,901 + + +
Males 3,113 2,496 1,497 1,412 + + 9,017 + + +
Females 2,454 1,716 1,346 1,064 + + 6,884 + + +

Estimated prevalence percent a on January 1, 2014, of the SEERc population diagnosed in the previous 22 years
By Age at Prevalence, Race/Ethnicity and Sex

WARNING: The Prevalence Estimates presented on this page utilize a different tumor selection criteria from previous CSR releases and are NOT directly comparable to estimates from previous CSR releases.
Please see the Prevalence Comparison Chapter of this CSR for more information.

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedf
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races c Both Sexes 0.0198% 0.0270% 0.0527% 0.0380% 0.0107% 0.0065% 0.0049% 0.0057% 0.0046% 0.0028% 0.0204%
Males 0.0224% 0.0276% 0.0571% 0.0432% 0.0133% 0.0074% 0.0059% 0.0055% 0.0054% 0.0039% 0.0226%
Females 0.0172% 0.0263% 0.0480% 0.0326% 0.0080% 0.0057% 0.0040% 0.0059% 0.0039% 0.0021% 0.0183%
White c Both Sexes 0.0225% 0.0310% 0.0606% 0.0450% 0.0134% 0.0070% 0.0054% 0.0062% 0.0048% 0.0024% 0.0236%
Males 0.0252% 0.0312% 0.0654% 0.0503% 0.0165% 0.0079% 0.0062% 0.0059% 0.0062% 0.0026% 0.0258%
Females 0.0198% 0.0307% 0.0555% 0.0394% 0.0101% 0.0060% 0.0045% 0.0064% 0.0036% 0.0023% 0.0213%
Black c Both Sexes 0.0100% 0.0116% 0.0230% 0.0179% 0.0042% 0.0041% 0.0027% 0.0030% - - 0.0093%
Males 0.0119% 0.0137% 0.0265% 0.0201% 0.0052% 0.0047% 0.0034% - - - 0.0107%
Females 0.0082% 0.0095% 0.0194% 0.0158% 0.0033% 0.0036% 0.0021% 0.0035% - - 0.0079%
Asian/
Pacific
Islander c		 Both Sexes 0.0137% 0.0204% 0.0414% 0.0232% 0.0045% 0.0058% 0.0041% 0.0043% 0.0042% 0.0040% 0.0148%
Males 0.0161% 0.0213% 0.0443% 0.0292% 0.0052% 0.0060% 0.0060% 0.0043% - 0.0106% 0.0166%
Females 0.0114% 0.0195% 0.0382% 0.0171% 0.0038% 0.0057% 0.0026% 0.0042% 0.0062% - 0.0131%
Hispanic d Both Sexes 0.0287% 0.0315% 0.0621% 0.0464% 0.0135% 0.0091% 0.0073% 0.0097% 0.0081% - 0.0250%
Males 0.0322% 0.0321% 0.0670% 0.0539% 0.0175% 0.0106% 0.0093% 0.0066% 0.0079% - 0.0277%
Females 0.0252% 0.0310% 0.0569% 0.0383% 0.0093% 0.0077% 0.0053% 0.0123% 0.0084% - 0.0222%

Footnotes:

a US 2014 cancer prevalence counts are based on 2014 cancer prevalence proportions from the SEER registries and 1/1/2014 US population estimates based on the average of 2013 and 2014 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 39/22 years.

b Statistics based on SEER 9 Areas.

c Statistics based on SEER 13 Areas excluding the Alaska Native Registry

d Statistics based on NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry.

e Maximum limited-duration prevalence: 39 years for 1975-2014 SEER 9 data; 22 years for 1992-2014 SEER 13 data (excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders.

f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

g Cases diagnosed more than 39 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

h Complete prevalence is obtained by summing 0 to <39 and >=39.

i Age-specific completeness index was approximated using empirical data from historical Connecticut tumor registry.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.